状细胞疾病管理中的最新方法和更新:系统性审查

相关实验视频

Updated: Jun 13, 2025

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy

Zeel Vishnubhai Patel¹, Priyadarshi Prajjwal², Lakshmi Deepak Bethineedi³

¹Internal Medicine, Medical College Baroda, Baroda, Gujarat, India.

Journal of blood medicine

|September 17, 2024

概括

状细胞疾病 (SCD) 的治疗方法正在进步. 最近的疗法为管理贫血和疼痛等并发症提供了新的方法,改善了患者的治疗结果.

科学领域:

血液学血液学血液学
遗传学是一个遗传学.
药理学药理学是指药理学的学科.

背景情况:

状细胞疾病 (SCD) 是一种常见的遗传性血液疾病,由β-环球蛋白基因突变引起,导致异常的血红蛋白S和状红细胞.
SCD会导致血液溶解,内皮损伤和血管封闭性危机,导致严重的急性和慢性健康并发症.
几十年来,SCD的治疗选择是有限的,氨酸urea和deferiprone是FDA批准的主要治疗方法.

研究的目的:

审查状细胞疾病新批准疗法的作用机制,实际考虑和副作用.
提供SCD管理的最新进展的概述.
突出解决急性和慢性SCD表现的新兴治疗方法.

主要方法:

使用包括PubMed,Medline和Cochrane在内的数据库进行了全面的文献搜索.
该审查侧重于最近批准的SCD疗法,分析其疗效和安全性.
综合了关于新药作用机制和临床考虑的信息.

主要成果:

自2017年以来,已经出现了几种FDA批准的新疗法,包括L-glutamine,voxelotor,crizanlizumab,exagamglogene autotemcel (Casgevy) 和lovotibeglogene autotemcel (Lyfgenia).
这些新的治疗方法在治疗各种SCD并发症,如溶血性贫血,慢性疼痛,中风,血管闭塞危机和器官损伤等方面表现出有效性.
该审查详细介绍了与每个新治疗剂相关的特定益处和潜在不良影响.

结论:

最近的治疗创新为治疗状细胞病及其相关并发症提供了显著的改善.
这些新兴的治疗方法为患者提供了新的希望,解决了SCD护理中以前未得到满足的需求.
这些疗法的进一步研究和临床应用对于优化患者的治疗结果至关重要.

关键词:

卡斯格维·卡斯格维·卡斯格维是什么意思在Crizanlizumab中使用.L-谷氨胺是一种L-谷氨胺.这就是Lyfgenia.这是一个Voxelotor.状细胞疾病是一种状细胞疾病.

更多相关视频

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload

Published on: March 14, 2017

Characterization of Sickling During Controlled Automated Deoxygenation with Oxygen Gradient Ektacytometry

Characterization of Sickling During Controlled Automated Deoxygenation with Oxygen Gradient Ektacytometry

Published on: November 5, 2019

相关概念视频

Methods of Documentation VI: Case Management Model

Methods of Documentation VI: Case Management Model

The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic...

Mesenchymal Stem Cells

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...

Bone Marrow Sampling and Transplants

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...

Inflammatory Bowel Disease IV: Pharmacological Management

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...

Diabetes: Management and Pharmacotherapy

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...

Regulation of Hematopoietic Stem Cells

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...